Want to see EHC full AI Analyst Report?
EHC Stock Chart & Stats
$112.89
$1.83(1.65%)
At close: 4:00 PM EDT
$112.89
$1.83(1.65%)
Day’s Range― - ―
52-Week Range$92.77 - $127.99
Previous CloseN/A
Volume816.66K
Average Volume (3M)1.06M
Market Cap
$11.20B
Enterprise Value$13.17K
Total Cash (Recent Filing)$200.50M
Total Debt (Recent Filing)$2.79B
Price to Earnings (P/E)18.6
Beta0.55
Next Earnings
Aug 05, 2026EPS Estimate
1.48Next Dividend Ex-DateN/A
Dividend Yield0.67%
Share Statistics
EPS (TTM)6.08
Shares Outstanding99,199,080
10 Day Avg. Volume899,771
30 Day Avg. Volume1,064,202
Financial Highlights & Ratios
PEG Ratio0.78
Price to Book (P/B)4.37
Price to Sales (P/S)1.80
P/FCF Ratio24.29
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$136.25Price Target Upside20.69% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering7
EPS Forecast (FY)6
Revenue Forecast (FY)$6.42B
Bulls Say, Bears Say
Bulls Say
Steady Revenue & ProfitabilityEncompass has delivered consistent top-line expansion over multiple years with durable profitability metrics: TTM net margin around 10% and EBITDA in the mid-20s, coupled with ~24% ROE. That steady revenue and margin profile supports long-term cash generation and investment in scaleable post-acute services.
Cash Generation & Capital AllocationOperating cash generation has been robust enough to fund growth and shareholder returns: Q1 adjusted FCF was $194M while management executed share repurchases and maintained a dividend. A sub-2x net leverage provides flexibility to invest in development and sustain capital returns over the medium term.
Development Pipeline & Capacity GrowthA sizeable multi-year development pipeline (multiple de novos, bed adds and small-format hospitals) addresses capacity constraints and supports organic growth. These durable expansion projects strengthen market footprint, raise revenue potential, and diversify site mix over 2–5 years.
Bears Say
Weaker FCF ConversionAlthough operating cash flow is generally healthy, trailing‑12‑month free cash flow has weakened materially versus net income, likely from higher capex or working capital timing. Persistently lower FCF conversion would constrain funding for growth, buybacks or debt amortization over the medium term.
Regulatory & Reimbursement RiskOngoing policy and reimbursement shifts (CMS rulemaking, TEAM/RCD rollouts) plus variability in Medicare Advantage utilization create structural revenue and admissions uncertainty. Such regulatory drift can alter reimbursement rates and admission patterns over multiple years, affecting margins and growth visibility.
Capacity Constraints In High‑Demand MarketsHigh occupancy in many hospitals (a third above 90%) limits near-term same‑store discharge upside and can shift revenue growth timing. Addressing these bottlenecks requires capital and time to add beds or open new sites, creating a structural constraint on organic growth until pipeline projects complete.
Encompass Health News
EHC FAQ
What was Encompass Health’s price range in the past 12 months?
Encompass Health lowest stock price was $92.77 and its highest was $127.99 in the past 12 months.
What is Encompass Health’s market cap?
Encompass Health’s market cap is $11.20B.
When is Encompass Health’s upcoming earnings report date?
Encompass Health’s upcoming earnings report date is Aug 05, 2026 which is in 8 days.
How were Encompass Health’s earnings last quarter?
Encompass Health released its earnings results on Apr 30, 2026. The company reported $1.6 earnings per share for the quarter, beating the consensus estimate of $1.494 by $0.106.
Is Encompass Health overvalued?
According to Wall Street analysts Encompass Health’s price is currently Undervalued.
Does Encompass Health pay dividends?
Encompass Health pays a Quarterly dividend of $0.21 which represents an annual dividend yield of 0.67%. See more information on Encompass Health dividends here
What is Encompass Health’s EPS estimate?
Encompass Health’s EPS estimate is 1.48.
How many shares outstanding does Encompass Health have?
Encompass Health has 99,199,080 shares outstanding.
What happened to Encompass Health’s price movement after its last earnings report?
Encompass Health reported an EPS of $1.6 in its last earnings report, beating expectations of $1.494. Following the earnings report the stock price went up 7.479%.
Which hedge fund is a major shareholder of Encompass Health?
Currently, no hedge funds are holding shares in EHC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Encompass Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$136.25 (20.69% Upside)
$136.25 (20.69% Upside)
Blogger Sentiment
Bullish
EHC Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 352.2K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $3.0M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▼ 1.0%
Last 30 Days ▲ 10.6%
Last 30 Days ▲ 10.6%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
6.13%
12-Months-Change
Fundamentals
Return on Equity
0.67%
Trailing 12-Months
Asset Growth
10.12%
Trailing 12-Months
Company Description
Encompass Health
Encompass Health Corporation (EHC) is a U.S. healthcare services company focused on post-acute care. Through a national network of inpatient rehabilitation hospitals and a home health and hospice platform, the company provides rehabilitative treatment following serious illness or injury as well as skilled services delivered in patients’ homes, including end-of-life care. Its core offerings include inpatient rehabilitation (IRF) services and home-based clinical care (home health and hospice).
EHC Company Deck
EHC Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presented multiple material operating and financial wins: double-digit EBITDA growth, revenue growth, improved clinical quality metrics, lower RN turnover, meaningful decline in premium labor, strong free cash flow and an expanded development pipeline. Offsetting these positives were manageable headwinds: short-term volume impact from unit closures (~85 bps), a one-time increase in bad debt tied to legacy claim write-offs, MA utilization variability, regulatory implementation risk and localized capacity constraints in high-demand markets. Management emphasized plans to address capacity via bed adds, de novos, joint ventures and small-format hospitals, and raised full-year guidance based on Q1 performance. Overall, positives materially outweighed the negatives.View all EHC earnings summariesEHC Stock 12 Month Forecast
Average Price Target
$136.25
▲(20.69% Upside)
Technical Analysis
DaVita
―
Fresenius Medical Care
―
Tenet Healthcare
―
The Ensign Group
―
Universal Health
―
Ownership Overview
1.20% Insiders
31.56% Mutual Funds
2.20% Other Institutional Investors
41.59% Public Companies and
Individual Investors